Results 81 to 90 of about 1,149,511 (200)

University of California Radiation Laboratory Reports UCRL-1729

, 1952
Quarterly summary report of studies conducted through the Radiation Laboratory, University of California.
Lawrence Radiation Laboratory
core  

Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis

, 2007
47th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology -- OCT 16-20, 2005 -- Denver, COPurpose: Clinical and 3D dosimetric parameters are associated with symptomatic radiation pneumonitis rates in retrospective studies.
Zeng, Jing, Zhou, Sumin, Hollis, Donna R., Borst, Gerben R., Zhang, Junan, Kocak, Zafer, Evans, Elizabeth S.   +6 more
core   +1 more source

Comparison of in‐field secondary cancer risk based on therapeutic proton dose between proton arc therapy and intensity‐modulated proton therapy in lung cancer patients

Journal of Applied Clinical Medical Physics, Volume 27, Issue 9, September 2026.
Abstract Background Proton arc therapy (PAT) is an emerging delivery modality that delivers proton beams through continuous gantry rotation combined with spot scanning. Compared with intensity‐modulated proton therapy (IMPT), PAT improves target conformity and spares organs at risk. However, the dynamic multi‐angle irradiation pattern may alter the low‐
Yuankang Xu, Wenguang Chen, Junxiang Wu, Hao Guo, Fanrui Zeng, Tianyu Zhang, Feng Yang, Xinhui Huang, Da Zhang, Xianliang Wang   +9 more
wiley   +1 more source

University of California Radiation Laboratory Report UCRL-769

, 1950
A quarterly summary of reports that have been published on research being conducted at the University of California Radiation ...
University of California. Radiation Laboratory.
core  

Essential Updates 2024–2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization

Annals of Gastroenterological Surgery, Volume 10, Issue 5, Page 1368-1381, September 2026.
This review summarizes key advances from 2024 to 2025 that are reshaping esophageal cancer surgery toward a strategy‐oriented, personalized paradigm through the integration of immunotherapy, population aging, and intelligent technologies. Adjuvant nivolumab after neoadjuvant chemoradiotherapy remains the only perioperative approach with durable benefit,
Shuichiro Oya, Koichi Yagi, Yoshifumi Baba   +2 more
wiley   +1 more source

Radiation Pneumonitis in Patients with Non–Small-Cell Lung Cancer Treated with Erlotinib Concurrent with Thoracic Radiotherapy [PDF]

, 2014
Introduction:The aim of this study was to investigate the incidence of radiation pneumonitis in patients with non–small-cell lung cancer treated with concurrent thoracic radiotherapy and erlotinib.Methods:Patients with inoperable stages IIIA to IV non ...
Zhuang, Hongqing, Pang, Qingsong, Zhao, Lujun, Yuan, Zhiyong, Wang, Jun, Wang, Ping, Chang, Joe Y.   +6 more
core   +1 more source

High-Grade Pneumonitis Events in Patients With Unresectable, Locally Advanced NSCLC Treated With Definitive Chemoradiation Followed by Adjuvant Durvalumab

JTO Clinical and Research Reports
Background: The standard of care for unresectable locally advanced NSCLC is concurrent chemotherapy and radiation (CRT) followed by adjuvant durvalumab, established by the PACIFIC trial, which revealed acceptable although higher rates of pneumonitis with
Ciani Ellison, MD, Michael Martens, PhD, Juliana Alvarez Argote, MD, Samantha Benz, MD, Adam Currey, MD, Candice Johnstone, MD, MPH, Slade Klawikowski, PhD, Katie Livingston, MD, John M. Longo, MD, Smitha Menon, MD, Saryleine Ortiz de Choudens, MD, Lindsay Puckett, MD, Janet Retseck, MD, PhD, Monica Shukla, MD, Jonathan Thompson, MS, MD, Elizabeth Gore, MD, FACR   +15 more
doaj   +1 more source

University of California Radiation Laboratory Reports UCRL-1854

, 1952
Quarterly summary report of studies conducted through the University of California Radiation Laboratory.
University of California. Radiation Laboratory.
core  

Improved Locoregional Recurrence‐Free Survival With Carbon Ion Versus Photon Radiotherapy in Locally Advanced Non‐Small Cell Lung Cancer

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Introduction Carbon ion radiotherapy (CIRT) delivers high linear energy transfer radiation with superior dose conformity compared with photon radiotherapy (PRT). However, whether these physical advantages translate into clinical benefit for locally advanced non‐small cell lung cancer (LA‐NSCLC) in the era of modern systemic therapy remains ...
Yonglong Liu, Ningyi Ma, Yaqi Li, Jing Mi, Xingwen Fan, Jian Chen, Jingfang Mao, Guoliang Jiang, Kailiang Wu   +8 more
wiley   +1 more source

Immunotherapy-Related Pneumonitis and the Synergic Impact of Thoracic Radiation and Preexisting Interstitial Lung Disease

, 2023
PURPOSE OF REVIEW: Immune checkpoint inhibitors (ICIs) are the frontline of therapy for most cancers. Although ICIs are sometimes considered to be less harmful than systemic chemotherapies, ICIs may cause immune-related adverse events, which are cases of
Abrencillo, Rodeo, Altan, Mehmet, Azhar, Maria, Gandhi, Saumil, Sheshadri, Ajay   +4 more
core   +1 more source